Tag results:
PI3K
Cancer Stem Cell News
Circulating Tumor Cell Copy-Number Heterogeneity in ALK-Rearranged Non-Small-Cell Lung Cancer Resistant to ALK Inhibitors
[npj Precision Oncology] Researchers provided in-depth investigation of copy number alteration heterogeneity in phenotypically characterized circulating tumor cells at resistance to Anaplastic Lymphoma Kinase (ALK)-tyrosine kinase inhibitors in ALK-positive non-small cell lung cancer.
Pulmonary Cell News
Combined FGFR and Akt Pathway Inhibition Abrogates Growth of FGFR1 Overexpressing EGFR-TKI-Resistant NSCLC Cells
[npj Precision Oncology] Researchers identified increased fibroblast growth factor receptor 1 (FGFR1) expression and Akt activation across erlotinib, gefitinib, and osimertinib EGFR-tyrosine kinase inhibitor (TKI)-resistant cell line models.
Pancreatic Cell News
Pancreatic Extracellular Matrix/Alginate Hydrogels Provide a Supportive Microenvironment for Insulin-Producing Cells
[ACS Biomaterials Science & Engineering] Hydrogel prepared with alginate and the pancreatic extracellular matrix was assessed for the beneficial outcomes on encapsulated insulin-producing cells.
Dermal Cell News
STAT3-Induced ZBED3-AS1 Promotes the Malignant Phenotypes of Melanoma Cells by Activating PI3K/AKT Signaling Pathway
[RNA Biology] Researchers discovered that ZBED3 antisense RNA 1 (ZBED3-AS1) was overexpressed in melanoma cells compared with human epidermal melanocytes.
Pulmonary Cell News
PTEN Loss Promotes Oncogenic Function of STMN1 via PI3K/AKT Pathway in Lung Cancer
[Scientific Reports] Researchers found that Stathmin (STMN1) was overexpressed in lung cancer tissues and associated with worse survival rates of lung cancer patients.
Endothelial Cell News
TAGLN, a Canonical Marker of Smooth Muscle Cells, Is Present in Endothelial Cells and Involved in Angiogenesis
[Journal of Cell Science] Human umbilical vein endothelial cells (HUVECs) elongated, activated TAGLN promoter and increased TAGLN transcripts in angiogenesis model. Genetic disruption of TAGLN augmented angiogenic behaviors of HUVECs, as did the disruption of TAGLN2 and TAGLN3 genes.